Survey to evaluate and summarize advances in immune recovery after allogeneic HSCT, focusing on the recovered immune subsets likely to have the greatest impact on clinical outcomes. Study type Retrospective Studies Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator
Subsequent allogeneic SCT in pediatric patients: Indications, procedures and outcome Study type Retrospective Studies Diseases Other myeloid or lymphoid malignancies Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator
Non relapse mortality after alloHSCT for ALL according to donor type and age groups in subsequent time periods Study type Retrospective Studies Diseases Acute Lymphatic Leukaemia (ALL) Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Sebastian Giebel
Comparison of RIC-AlloHSCT vs. autoHSCT for ALL > 55 years old Study type Retrospective Studies Diseases Acute Lymphatic Leukaemia (ALL) Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Sebastian Giebel
Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Leukemia Study type Retrospective Studies Diseases Other myeloid or lymphoid malignancies Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Norbert Claude Gorin
Impact of HLA disparities on outcome after haploidentical transplantation Study type Retrospective Studies Diseases Other myeloid or lymphoid malignancies Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Francesca Lorentino
Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Paediatric Multiple Sclerosis Study type Retrospective Studies Diseases Auto immune disorders Group Autoimmune Diseases Working Party (ADWP) Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator J Burman, K Kirgizov
RACE: A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients Study type Clinical Trials Diseases Bone marrow failure Group Severe Aplastic Anaemia Working Party (SAAWP) Type of transplant Principal investigator Antonio Risitano, Regis Peffault de Latour
A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients Study type Clinical Trials Diseases Complications: infectious Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Type of transplant Principal investigator
Resistance pattern of Gram-negative bacteria isolated from blood from HSCT recipients Study type Non-interventional Prospective Studies Diseases Complications: infectious Group Infectious Diseases Working Party (IDWP) Type of transplant Principal investigator Dina Averbuch
LYM1: Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Study type Clinical Trials Diseases Non-Hodgkin’s Lymphoma (NHL) Group Lymphoma Working Party (LWP) Type of transplant Principal investigator Ruth Pettengell
ASTIMS: High dose immunoablation and autologous haematopoietic stem cell transplantation versus mitoxantrone therapy in severe multiple sclerosis Study type Clinical Trials Diseases Auto immune disorders Group Autoimmune Diseases Working Party (ADWP) Type of transplant Principal investigator G.L. Mancardi